Tammy I. Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tammy I. Kang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Chris Feudtner
The Pediatric Advanced Care TeamThe Children's Hospital of Philadelphia, Philadelphia, USA
2 shared publications- Chris Feudtner
Division of General Pediatrics (C.F.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
2 shared publications - Kari R. Hexem
The Pediatric Advanced Care Team, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA
2 shared publications - Abby R. Rosenberg
Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA
1 shared publication - Chris Feudtner
The Children’s Hospital of Philadelphia
1 shared publication - Cynthia A. Gerhardt
The Research Institute at Nationwide Children’s Hospital, Columbus, United States
1 shared publication
Latest Publications
- Open Access
- 5 December 2015
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2015 (1) , 490-495
Palliative care in pediatric patients with hematologic malignancies
Children with advanced cancer, including those with hematologic malignancies, can benefit from interdisciplinary palliative care services. Palliative care includes management of distressing symptoms, attention to psychosocial and spiritual needs, and assistance with navigating complex medical decisions with the ultimate goal of maximizing the quality-of-life of the child and family. Palliative care is distinct from hospice care and can assist with the care of patients throughout the cancer continuum, irrespective of prognosis. While key healthcare organizations, including the Institute of Medicine, the American Academy of Pediatrics and the American Society of Clinical Oncology among many others endorse palliative care for children with advanced illness, barriers to integration of palliative care into cancer care still exist. Providing assistance with advance care planning, guiding patients and families through prognostic uncertainty, and managing transitions of care are also included in goals of palliative care involvement. For patients with advanced malignancy, legislation, included in the Patient Protection and Affordable Health Care Act allows patients and families more options as they make the difficult transition from disease directed therapy to care focused on comfort and quality-of-life.
- 5 December 2015
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2015 (1) , 490-495
Open AccessPalliative care in pediatric patients with hematologic malignancies
Children with advanced cancer, including those with hematologic malignancies, can benefit from interdisciplinary palliative care services. Palliative care includes management of distressing symptoms, attention to psychosocial and spiritual needs, and assistance with navigating complex medical decisions with the ultimate goal of maximizing the quality-of-life of the child and family. Palliative care is distinct from hospice care and can assist with the care of patients throughout the cancer continuum, irrespective of prognosis. While key healthcare organizations, including the Institute of Medicine, the American Academy of Pediatrics and the American Society of Clinical Oncology among many others endorse palliative care for children with advanced illness, barriers to integration of palliative care into cancer care still exist. Providing assistance with advance care planning, guiding patients and families through prognostic uncertainty, and managing transitions of care are also included in goals of palliative care involvement. For patients with advanced malignancy, legislation, included in the Patient Protection and Affordable Health Care Act allows patients and families more options as they make the difficult transition from disease directed therapy to care focused on comfort and quality-of-life.
- Open Access
- 13 March 2014
- Published by Springer Nature in BMC Palliative Care
- Vol. 13 (1) , 9
Regoaling: a conceptual model of how parents of children with serious illness change medical care goals
Parents of seriously ill children participate in making difficult medical decisions for their child. In some cases, parents face situations where their initial goals, such as curing the condition, may have become exceedingly unlikely. While some parents continue to pursue these goals, others relinquish their initial goals and generate new goals such as maintaining the child’s quality of life. We call this process of transitioning from one set of goals to another regoaling. Regoaling involves factors that either promote or inhibit the regoaling process, including disengagement from goals, reengagement in new goals, positive and negative affect, and hopeful thinking. We examine these factors in the context of parental decision making for a seriously ill child, presenting a dynamic conceptual model of regoaling. This model highlights four research questions that will be empirically tested in an ongoing longitudinal study of medical decision making among parents of children with serious illness. Additionally, we consider potential clinical implications of regoaling for the practice of pediatric palliative care. The psychosocial model of regoaling by parents of children with a serious illness predicts that parents who experience both positive and negative affect and hopeful patterns of thought will be more likely to relinquish one set of goals and pursue a new set of goals. A greater understanding of how parents undergo this transition may enable clinicians to better support them through this difficult process.
- 13 March 2014
- Published by Springer Nature in BMC Palliative Care
- Vol. 13 (1) , 9
Open AccessRegoaling: a conceptual model of how parents of children with serious illness change medical care goals
Parents of seriously ill children participate in making difficult medical decisions for their child. In some cases, parents face situations where their initial goals, such as curing the condition, may have become exceedingly unlikely. While some parents continue to pursue these goals, others relinquish their initial goals and generate new goals such as maintaining the child’s quality of life. We call this process of transitioning from one set of goals to another regoaling. Regoaling involves factors that either promote or inhibit the regoaling process, including disengagement from goals, reengagement in new goals, positive and negative affect, and hopeful thinking. We examine these factors in the context of parental decision making for a seriously ill child, presenting a dynamic conceptual model of regoaling. This model highlights four research questions that will be empirically tested in an ongoing longitudinal study of medical decision making among parents of children with serious illness. Additionally, we consider potential clinical implications of regoaling for the practice of pediatric palliative care. The psychosocial model of regoaling by parents of children with a serious illness predicts that parents who experience both positive and negative affect and hopeful patterns of thought will be more likely to relinquish one set of goals and pursue a new set of goals. A greater understanding of how parents undergo this transition may enable clinicians to better support them through this difficult process.
- 1 June 2013
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 167 (6) , 537-543
Psychological Distress in Parents of Children With Advanced Cancer
Parent psychological distress can impact the well-being of childhood cancer patients and other children in the home. Recognizing and alleviating factors of parent distress may improve overall family survivorship experiences following childhood cancer. To describe the prevalence and factors of psychological distress (PD) among parents of children with advanced cancer. Cohort study embedded within a randomized clinical trial (Pediatric Quality of Life and Evaluation of Symptoms Technology [PediQUEST] study). Multicenter study conducted at 3 children's hospitals (Boston Children's Hospital, Children's Hospital of Philadelphia, and Seattle Children's Hospital). Parents of children with advanced (progressive, recurrent, or refractory) cancer. Parental PD, as measured by the Kessler-6 Psychological Distress Scale. Eighty-six of 104 parents completed the Survey About Caring for Children With Cancer (83% participation); 81 parents had complete Kessler-6 Psychological Distress Scale data. More than 50% of parents reported high PD and 16% met criteria for serious PD (compared with US prevalence of 2%-3%). Parent perceptions of prognosis, goals of therapy, child symptoms/suffering, and financial hardship were associated with PD. In multivariate analyses, average parent Kessler-6 Psychological Distress Scale scores were higher among parents who believed their child was suffering highly and who reported great economic hardship. Conversely, PD was significantly lower among parents whose prognostic understanding was aligned with concrete goals of care. Parenting a child with advanced cancer is strongly associated with high to severe levels of PD. Interventions aimed at aligning prognostic understanding with concrete care goals and easing child suffering and financial hardship may mitigate parental PD.
- 1 June 2013
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 167 (6) , 537-543
Psychological Distress in Parents of Children With Advanced Cancer
Parent psychological distress can impact the well-being of childhood cancer patients and other children in the home. Recognizing and alleviating factors of parent distress may improve overall family survivorship experiences following childhood cancer. To describe the prevalence and factors of psychological distress (PD) among parents of children with advanced cancer. Cohort study embedded within a randomized clinical trial (Pediatric Quality of Life and Evaluation of Symptoms Technology [PediQUEST] study). Multicenter study conducted at 3 children's hospitals (Boston Children's Hospital, Children's Hospital of Philadelphia, and Seattle Children's Hospital). Parents of children with advanced (progressive, recurrent, or refractory) cancer. Parental PD, as measured by the Kessler-6 Psychological Distress Scale. Eighty-six of 104 parents completed the Survey About Caring for Children With Cancer (83% participation); 81 parents had complete Kessler-6 Psychological Distress Scale data. More than 50% of parents reported high PD and 16% met criteria for serious PD (compared with US prevalence of 2%-3%). Parent perceptions of prognosis, goals of therapy, child symptoms/suffering, and financial hardship were associated with PD. In multivariate analyses, average parent Kessler-6 Psychological Distress Scale scores were higher among parents who believed their child was suffering highly and who reported great economic hardship. Conversely, PD was significantly lower among parents whose prognostic understanding was aligned with concrete goals of care. Parenting a child with advanced cancer is strongly associated with high to severe levels of PD. Interventions aimed at aligning prognostic understanding with concrete care goals and easing child suffering and financial hardship may mitigate parental PD.
- 1 December 2012
- Published by Taylor & Francis in Progress in Palliative Care
- Vol. 20 (6) , 331-336
Advances in pediatric palliative medicine in the United States
Over the past decade, pediatric palliative medicine in the United States has advanced to a remarkable degree. This article situates these changes in the general context of the growth of adult-focused palliative medicine, and enumerates several landmark reports, studies, programmatic initiatives, and professional developments that serve as milestones marking the progress of the field, while also underscoring the continuing need to better educate families and health care providers about what pediatric palliative care can offer patients, to expand the evidence base regarding specific pediatric palliative care interventions, and to further our abilities to finance and improve these services.
- 1 December 2012
- Published by Taylor & Francis in Progress in Palliative Care
- Vol. 20 (6) , 331-336
Advances in pediatric palliative medicine in the United States
Over the past decade, pediatric palliative medicine in the United States has advanced to a remarkable degree. This article situates these changes in the general context of the growth of adult-focused palliative medicine, and enumerates several landmark reports, studies, programmatic initiatives, and professional developments that serve as milestones marking the progress of the field, while also underscoring the continuing need to better educate families and health care providers about what pediatric palliative care can offer patients, to expand the evidence base regarding specific pediatric palliative care interventions, and to further our abilities to finance and improve these services.
- 28 September 2012
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 60 (1) , 88-94
The use of palliative chemotherapy in pediatric oncology patients: A national survey of pediatric oncologists
Background Many children continue receiving chemotherapy after there is no realistic hope for cure. One factor that influences parental decisions to pursue medical therapies is physician preference. To date, no studies have described pediatric oncologists' perspectives and practices regarding palliative chemotherapy (PC). Procedure We surveyed via email pediatric oncologists practicing in the U.S who are members of the Children's Oncology Group to achieve the following objectives: (1) Describe pediatric oncologists treatment considerations regarding the use of PC. (2) Assess treatment considerations that influenced pediatric oncologists' therapy recommendations for their most recent patient receiving PC. There were 422 participants (40.8%) who completed the survey. Results The most important factors considered by pediatric oncologists when prescribing PC were the toxicity of the chemotherapy (4.90 mean SD = 0.36 utilizing 5 point scale with 1 = not important to 5 = very important), the preferences of the family (4.57; SD = 0.60), and the potential to decrease symptoms arising from tumor burden (4.42; SD = 0.65). These treatment considerations were not as important when PC was prescribed for their most recent patient. Similarly, the chief aims in prescribing PC were not achieved for recent patients receiving PC. For their most recent patient who received PC, 40.8% believe this treatment was primarily for parental wishes. Conclusion According to 80.2% of pediatric oncologists completing the survey, some patients receive chemotherapy beyond medical benefit and 40.8% of these oncologists have prescribed PC for the purpose of parental wishes to a recent patient. The chief aims in prescribing palliative chemotherapy were not achieved for recent patients. Pediatr Blood Cancer 2013; 60: 88–94.
- 28 September 2012
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 60 (1) , 88-94
The use of palliative chemotherapy in pediatric oncology patients: A national survey of pediatric oncologists
Background Many children continue receiving chemotherapy after there is no realistic hope for cure. One factor that influences parental decisions to pursue medical therapies is physician preference. To date, no studies have described pediatric oncologists' perspectives and practices regarding palliative chemotherapy (PC). Procedure We surveyed via email pediatric oncologists practicing in the U.S who are members of the Children's Oncology Group to achieve the following objectives: (1) Describe pediatric oncologists treatment considerations regarding the use of PC. (2) Assess treatment considerations that influenced pediatric oncologists' therapy recommendations for their most recent patient receiving PC. There were 422 participants (40.8%) who completed the survey. Results The most important factors considered by pediatric oncologists when prescribing PC were the toxicity of the chemotherapy (4.90 mean SD = 0.36 utilizing 5 point scale with 1 = not important to 5 = very important), the preferences of the family (4.57; SD = 0.60), and the potential to decrease symptoms arising from tumor burden (4.42; SD = 0.65). These treatment considerations were not as important when PC was prescribed for their most recent patient. Similarly, the chief aims in prescribing PC were not achieved for recent patients receiving PC. For their most recent patient who received PC, 40.8% believe this treatment was primarily for parental wishes. Conclusion According to 80.2% of pediatric oncologists completing the survey, some patients receive chemotherapy beyond medical benefit and 40.8% of these oncologists have prescribed PC for the purpose of parental wishes to a recent patient. The chief aims in prescribing palliative chemotherapy were not achieved for recent patients. Pediatr Blood Cancer 2013; 60: 88–94.
- 1 January 2011
- Published by American Psychological Association (APA)
Nurses' Palliative, End-of-Life, and Bereavement Care Survey
- 1 January 2011
- Published by American Psychological Association (APA)
Nurses' Palliative, End-of-Life, and Bereavement Care Survey